Stay updated with breaking news from Advanced Sample. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bluechiip Limited (ASX:BCT) (FRA:1BL) understands that every biological sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way.
Open Briefing interview with Bluechiip Limited (ASX:BCT) MD Andrew McLellan.
Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release the company's Appendix 4C - Quarterly Cashflow report and update for the quarter ended 30 June 2022.
Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release its Appendix 4C - Quarterly Cashflow report and update for the quarter ended 31 December 2021.
In this Open Briefing(R), Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan discusses cash receipts from initial orders and deliveries of own product range, expectation for increasing revenues based on existing orders and growing enquiry pipeline, new patent award and developer kit sales and OEM negotiations.